quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:30:34·70d
SECFiling
Indaptus Therapeutics Inc. logo

Indaptus Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

INDP· Indaptus Therapeutics Inc.
Health Care
Original source

Companies

  • INDP
    Indaptus Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 31UpdateHC Wainwright & Co.$15.00
  • Oct 19UpdateMaxim Group$16.00

Related

  • SEC1d
    Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • INSIDER3d
    SEC Form 3 filed by new insider Lu Qinglai
  • SEC17d
    Amendment: SEC Form SCHEDULE 13G/A filed by Indaptus Therapeutics Inc.
  • SEC20d
    Indaptus Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • INSIDER21d
    SEC Form 3 filed by new insider Yao Yun
  • INSIDER21d
    SEC Form 3 filed by new insider Sino Lion Ventures Ltd
  • INSIDER21d
    SEC Form 3 filed by new insider Dai Junyi
  • SEC30d
    Indaptus Therapeutics Inc. filed SEC Form 8-K: Changes in Control of Registrant, Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022